Top Markets
#1 Pons Pons +54.09%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Purr Purr +49.34%
#4 Kinetiq Kinetiq +27.31%
#5 Non-Playable Coin Non-Playable Coin +26.21%
#6 ApeX ApeX +25.57%
#7 Pudgy Penguins Pudgy Penguins +21.07%
#8 OriginTrail OriginTrail +20.36%
#9 Morpho Morpho +20.09%
#10 Grass Grass +19.96%
Coin of the day
Pons Pons
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
3B BlackBio Dx Ltd 3B BlackBio Dx Ltd

3B BlackBio Dx Ltd

3BBLACKBIO
Clasificación en acciones #21276
Established in 1972 and headquartered in Bhopal, India, 3B Blackbio Dx Limited... Established in 1972 and headquartered in Bhopal, India, 3B Blackbio Dx Limited specializes in the conception, production, and market distribution of sophisticated molecular diagnostic technologies. The company's core focus is on delivering solutions for pressing health concerns such as infectious diseases, oncology, human genetics, and the challenge of antimicrobial resistance, primarily serving the Indian market. Their comprehensive product portfolio includes qPCR-based assays, swift lateral flow rapid tests, and cutting-edge Next Generation Sequencing (NGS) molecular diagnostic kits. These offerings are designed to enable precise and dependable analysis of patient samples by diagnostic laboratories, marketed under reputable brands like TRUPCR, TRUNGS, and TRURAPID. Beyond diagnostics, 3B Blackbio Dx Limited also supplies agrochemical products and provides essential technical support and training services.
Precio por acción
$12.94
Última sincronización: 2026-08-21
Capitalización bursátil
$111.10M
Cambio (1 día)
3.03%
Cambio (1 año)
-21.30%
País
IN
Comercio 3B BlackBio Dx Ltd (3BBLACKBIO)

Categoría

Healthcare
Ganancias de 3B BlackBio Dx Ltd (3BBLACKBIO)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di 3B BlackBio Dx Ltd, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de 3B BlackBio Dx Ltd desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH